ROCHESTER, N.Y., Aug. 25, 2020 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced the Company will host a webinar with University of Louisville School of Medicine to discuss smart glasses usage in healthcare.
University of Louisville School of Medicine has successfully piloted Vuzix M400 Smart Glasses over the last several months for emergency response, medical education and training, and care of patients in nursing homes and aging in place. The upcoming webinar will feature presentations by Vuzix and Dr. R. Brent Wright, Associate Dean for Rural Health Innovation at the University of Louisville School of Medicine who recently served as the 169th President of the Kentucky Medical Association (KMA).
“Healthcare, has quickly emerged to become an important business segment for Vuzix, including telemedicine and telehealth solutions related to patient care, training and surgery, as well as providing technicians hands-free support within medical facilities,” said Paul Travers, Vuzix President and Chief Executive Officer. “We are pleased with the successful piloting of our M400 Smart Glasses at University of Louisville School of Medicine, one of the country’s oldest and most innovative medical schools.”
If you’re interested in learning more about Vuzix Smart Glasses and how they are being used in healthcare, you can register for the upcoming webinar via the link below.
Webinar Topic: Smart Glasses Usage in Healthcare Featuring Panelists from Vuzix and University of Louisville School of Medicine
Date: Thursday September 3, 2020
Start Time: 11:00 AM Eastern Time (ET)
Webinar/Registration Link:
https://vuzix.zoom.us/webinar/register/WN_e5–6pgKTxuyzyQVaRn-LA
About Vuzix Corporation
Vuzix is a leading supplier of Smart-Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company’s products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 166 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2020 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, and Tokyo, Japan. For more information, visit Vuzix website, Twitter and Facebook pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to the Vuzix Smart Glasses, our business relationship with University of Louisville, future business opportunities, and among other things the Company’s leadership in the Smart Glasses and AR display industry. They are generally identified by words such as “believes,” “may,” “expects,” “anticipates,” “should” and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
Media and Investor Relations Contact:
Ed McGregor, Director of Investor Relations, Vuzix Corporation ed_mcgregor@vuzix.com, Tel: (585) 359-5985
Vuzix Corporation, 25 Hendrix Road, Suite A, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com
John R. Karman III, Executive Director of Communications, Office of Communications and Marketing University of Louisville, john.karman@louisville.edu
View original content to download multimedia:http://www.prnewswire.com/news-releases/vuzix-to-host-webinar-with-university-of-louisville-school-of-medicine-to-discuss-smart-glasses-usage-in-healthcare-during-covid-19-and-beyond-301118116.html
SOURCE Vuzix Corporation
At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response…
Objective response rate of 69.2% observed in heavily pretreated patient population including patients with BTK…
The study met its primary endpoint of overall survival with a 41% reduction in the…
DENVER, CO / ACCESSWIRE / June 15, 2024 / Each year over 120,000 Coloradans are…
REYKJAVIK, Iceland, June 15, 2024 /PRNewswire/ -- In a recent display of global baking talent,…
– ENERGIZE is the First Study to Demonstrate Efficacy of an Oral Treatment for Non-Transfusion-Dependent Alpha-…